Arden Trust’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $2.99M | Sell |
20,435
-1,257
| -6% | -$187K | 0.42% | 44 |
|
|
2024
Q1 | $3.43M | Sell |
21,692
-535
| -2% | -$85.2K | 0.48% | 39 |
|
|
2023
Q4 | $3.48M | Sell |
22,227
-454
| -2% | -$69.6K | 0.51% | 38 |
|
|
2023
Q3 | $3.53M | Sell |
22,681
-2,143
| -9% | -$354K | 0.59% | 37 |
|
|
2023
Q2 | $4.11M | Sell |
24,824
-6,152
| -20% | -$993K | 0.67% | 31 |
|
|
2023
Q1 | $4.8M | Sell |
30,976
-4,012
| -11% | -$648K | 0.87% | 26 |
|
|
2022
Q4 | $6.18M | Buy |
34,988
+899
| +3% | +$155K | 1.26% | 15 |
|
|
2022
Q3 | $5.57M | Sell |
34,089
-1,345
| -4% | -$228K | 1.41% | 13 |
|
|
2022
Q2 | $6.29M | Sell |
35,434
-2,708
| -7% | -$482K | 1.44% | 13 |
|
|
2022
Q1 | $6.76M | Sell |
38,142
-2,268
| -6% | -$386K | 1.32% | 12 |
|
|
2021
Q4 | $6.91M | Sell |
40,410
-2,281
| -5% | -$373K | 1.17% | 12 |
|
|
2021
Q3 | $6.89M | Buy |
42,691
+602
| +1% | +$103K | 1.18% | 14 |
|
|
2021
Q2 | $6.93M | Sell |
42,089
-3,237
| -7% | -$536K | 1.14% | 14 |
|
|
2021
Q1 | $7.45M | Sell |
45,326
-1,536
| -3% | -$249K | 1.25% | 15 |
|
|
2020
Q4 | $7.38M | Sell |
46,862
-2,504
| -5% | -$370K | 1.22% | 14 |
|
|
2020
Q3 | $7.35M | Buy |
49,366
+536
| +1% | +$79.3K | 1.32% | 14 |
|
|
2020
Q2 | $6.87M | Buy |
48,830
+435
| +0.9% | +$63.4K | 1.26% | 13 |
|
|
2020
Q1 | $6.35M | Sell |
48,395
-5,961
| -11% | -$846K | 1.26% | 12 |
|
|
2019
Q4 | $7.93M | Buy |
54,356
+71
| +0.1% | +$9.63K | 1.25% | 13 |
|
|
2019
Q3 | $7.02M | Sell |
54,285
-1,129
| -2% | -$149K | 1.14% | 14 |
|
|
2019
Q2 | $7.72M | Sell |
55,414
-1,073
| -2% | -$149K | 1.3% | 9 |
|
|
2019
Q1 | $7.9M | Sell |
56,487
-1,314
| -2% | -$176K | 1.27% | 6 |
|
|
2018
Q4 | $7.46M | Sell |
57,801
-1,783
| -3% | -$249K | 1.34% | 6 |
|
|
2018
Q3 | $8.23M | Sell |
59,584
-4,293
| -7% | -$570K | 1.28% | 8 |
|
|
2018
Q2 | $7.75M | Sell |
63,877
-2,817
| -4% | -$351K | 1.23% | 9 |
|
|
2018
Q1 | $8.55M | Sell |
66,694
-3,490
| -5% | -$472K | 1.33% | 6 |
|
|
2017
Q4 | $9.81M | Sell |
70,184
-2,139
| -3% | -$298K | 1.48% | 6 |
|
|
2017
Q3 | $9.4M | Sell |
72,323
-1,275
| -2% | -$169K | 1.43% | 5 |
|
|
2017
Q2 | $9.74M | Sell |
73,598
-3,521
| -5% | -$449K | 1.49% | 5 |
|
|
2017
Q1 | $9.61M | Sell |
77,119
-1,136
| -1% | -$136K | 1.5% | 5 |
|
|
2016
Q4 | $9.02M | Sell |
78,255
-1,874
| -2% | -$216K | 1.37% | 7 |
|
|
2016
Q3 | $9.47M | Sell |
80,129
-105,702
| -57% | -$12.8M | 1.46% | 7 |
|
|
2016
Q2 | $22.5K | Sell |
185,831
-306
| -0.2% | -$34.8K | 1.7% | 3 |
|
|
2016
Q1 | $20.1M | Sell |
186,137
-5,591
| -3% | -$579K | 1.61% | 5 |
|
|
2015
Q4 | $19.7M | Buy |
191,728
+9,176
| +5% | +$923K | 1.66% | 4 |
|
|
2015
Q3 | $17M | Buy |
182,552
+49,134
| +37% | +$4.75M | 1.41% | 5 |
|
|
2015
Q2 | $13K | Sell |
133,418
-114
| -0.1% | -$11.4K | 1.95% | 3 |
|
|
2015
Q1 | $13.4K | Buy |
133,532
+54,153
| +68% | +$5.51M | 1.95% | 3 |
|
|
2014
Q4 | $8.3M | Sell |
79,379
-4,108
| -5% | -$433K | 1.15% | 10 |
|
|
2014
Q3 | $8.9M | Sell |
83,487
-2,612
| -3% | -$271K | 1.22% | 10 |
|
|
2014
Q2 | $9.01M | Sell |
86,099
-2,454
| -3% | -$248K | 1.23% | 11 |
|
|
2014
Q1 | $8.7M | Sell |
88,553
-961
| -1% | -$89.1K | 1.07% | 13 |
|
|
2013
Q4 | $8.2M | Buy |
89,514
+5,465
| +7% | +$504K | 1% | 14 |
|
|
2013
Q3 | $7.29M | Sell |
84,049
-16,267
| -16% | -$1.46M | 0.93% | 14 |
|
|
2013
Q2 | $8.61M | Buy |
+100,316
| New | +$8.51M | 1.05% | 12 |
|
Other funds holding JNJ
Arden Trust's JNJ Position: Q2 2024 in Review
Arden Trust reduced its Johnson & Johnson (JNJ) stake by 5.8% in Q2 2024, selling an estimated $187K and leaving 20,435 shares worth $2.99M. The position accounts for 0.42% of the portfolio, ranked #44.
Arden Trust first reported a position in JNJ in Q2 2013 and has held it in 45 quarters since. The position peaked at $20.1M in Q1 2016. 3,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.
- Arden Trust held 20,435 shares of Johnson & Johnson worth $2.99M as of Q2 2024.
- Arden Trust sold 1,257 Johnson & Johnson shares in Q2 2024, an estimated $187K.
- Johnson & Johnson made up 0.42% of Arden Trust's portfolio in Q2 2024, its #44 holding.
- Arden Trust first reported a position in Johnson & Johnson in Q2 2013 and has held it in 45 quarters since.
- Arden Trust's Johnson & Johnson position peaked at $20.1M in Q1 2016.
- 3,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.
Based on Arden Trust's 13F filing for Q2 2024, filed 9 Jul 2024.